HYPERTENSION - kau12/11/2010 Dr. Ahmed Elberry, MD 1 1 HYPERTENSION Dr. Ahmed A. Elberry, MBBCH,...
Transcript of HYPERTENSION - kau12/11/2010 Dr. Ahmed Elberry, MD 1 1 HYPERTENSION Dr. Ahmed A. Elberry, MBBCH,...
12/11/2010
Dr. Ahmed Elberry, MD 1
1
HYPERTENSION
Dr. Ahmed A. Elberry, MBBCH, MSc, MDAssistant Professor of Clinical Pharmacy
Faculty of pharmacy,KAU
Hypertension
• It is a sustained of arterial bl. pr. ≥ 140/90
• Causes:1. 1ry: “Essential” or “Idiopathic”: 90-95% of cases
2. 2ry: about 5% of cases Disease:
Renal or renovascular disease Coarctation of the aorta Endocrine disease: eg:
Phaeochomocytoma Cushing syndrome Acromegaly
Drugs (Iatrogenic)
2
12/11/2010
Dr. Ahmed Elberry, MD 2
Drug-Induced HT:
1- Hormones: Steroids Estrogens & OC Erythropoietin
2- Autonomic: Phenylpropanolamines Clonidine withdrawal Ergotamine
Sibutramine Methylphenidate
3- CNS: Anxiolytic: Buspirone Anesthetic:
Ketamine Desflurane
Antiparkinsonian: Bromocryptine Antiepileptic: Carbamazepine Antiemetic: Metoclopramide Antidepressants: Venlafaxine
4- Antiinflammatory: NSAIDs
5- Immunosuppressive:cyclosporine/tacrolimus
Risk factors for 1ry HT
Controllable RiskFactors
1- Salt intake2- Alcohol3- Stress4- Weight (Obesity)
5- exercise
Uncontrollable RiskFactors
1- Heredity2- Age
- Men: 35 – 50- Women: aftermenopause
3- Race :More inAfrican Americans
12/11/2010
Dr. Ahmed Elberry, MD 3
JNC 7 Classification of BP: The 7th report of the Joint National Committee on Detection, Evaluation
& Treatment of High Bl Pr (JNC 7) classifies adult BP as shown
5
Classification Systolic BP(mmHg)
Diastolic BP.(mmHg)
NormalPrehypertensionStage 1 hypertensionStage 2 hypertension
<120120–139140–159
≥160
<8080–8990–99≥100
NB.:• If systolic & diastolic lie in different stages, the highest is considered• Diastolic bl.pr. is generally more reliable, while, systolic is more important in elderly
Manifestations
Usually NO SYMPTOMS! “The Silent Killer” May have:
Headache Blurry vision Chest Pain Frequent urination at night
6
12/11/2010
Dr. Ahmed Elberry, MD 4
Complications of HT
7
Treatment of HT
• Nonpharmacological• Pharmacological
8
12/11/2010
Dr. Ahmed Elberry, MD 5
Non pharmacological therapy
Include:
Indication: patients with prehypertension. Patients diagnosed with stage 1 or 2 hypertension should be
placed on lifestyle modifications & drug therapy concurrently.
9
Approximate SBP Reduction1- Adopt DASH eating plan 8-14 mmHg2- Dietary sodium 2-8 mmHg3- Alcohol consumption 2-4 mmHg4- Weight 5-20 mmHg/ 10 kg weight loss5- Physical activity 4-9 mmHg
DASH Eating Plan
1. saturated fat, cholesterol & total fat2. red meat3. sweets & sugar containing
beverages
4. fruits, vegetables & fiber5. low fat diary products & plant protein6. magnesium, potassium & calcium
DASH Can reduce BP in 2 weeks(SBP, 8-14 mmHg)
12/11/2010
Dr. Ahmed Elberry, MD 6
Pharmacological treatment
1st line 1ry options: (ABCD) Diuretics, ACE inhibitors (or ARBs)* , CCBs & β-Blockers**
Alternatives: Sympatholytics:
central α2-agonists, α1-Blockers, peripheral adrenergic neurone antagonists (guanithidine, reserpine,
α-methyldopa) direct renin inhibitors (Aliskiren)
Direct arterial vasodilators: (hydralazine, minoxidil, diazoxide)
11
*ACE inhibitors (or ARBs) are contraindicated in pregnancy
**BBs are not indicated as first line therapy for elderly (age 60 and above)
The A B C D classes (1st line)
12
DIURETICS
First and Best Choice
Can be combined with A, B, C
βBlockers
Good third Choice
Can be combined with A, D
Ca channelBlockers
Fourth Choice, Useful
Can be combined with D, A
ACEI and ARB
Second Best Choice
Can be combined with D, B, C
D
Diuretics
A
ACEI, ARB
B
β-Blockers
C
Ca-Blockers
D A
B C
12/11/2010
Dr. Ahmed Elberry, MD 7
GOAL OF THERAPY
Stage 1: monotherapy Stage 2: combination therapy
13
Hypertension
With Framinghamrisk factor ˂10%
-PLUS-
1-Framingham risk factor˃10%2- DM3- Renal Disease4- CAD
-PLUS-
HF
< 140/90mmHg
< 130/80mmHg
< 120/80mmHg
14
12/11/2010
Dr. Ahmed Elberry, MD 8
Algorithm for Treatment of HT
Not at Goal Blood
Initial Drug Choices
Drug(s) for the compellingindications
With CompellingIndications
Lifestyle Modifications
Stage 2 HTN2-drug combination for most(usually thiazide diuretic and
ACEI, or ARB, or BB, or CCB)
Stage 1 HTNThiazide diuretics for most.May consider ACEI, ARB,BB, CCB, or combination.
Without CompellingIndications
Not at GoalBlood Pressure
Optimize dosages or add additional drugs
Compelling Indications
CompellingIndication
Initial Therapy Options Sequential therapy
Diabetes ACEI (or ARB) THIAZ, BB, CCB
Chronic kidneydisease (CKD)
ACEI (or ARB)
CAD BB + ACEI (or ARB) - THIAZ for BP control- CCB fro ischemia control
Recurrentstrokeprevention
ACEI (or ARB) + THIAZ
HF BB + THIAZ + ACEI (orARB)
- Aldosterone antagonist forsevere HF- Hydralazine or nitrates forblack patients
12/11/2010
Dr. Ahmed Elberry, MD 9
Diuretics
1. Thiazides: As hydrochlorthiazide (HCTZ) or chlorthalidone
2. Loop Diuretics: Furosemide (lasix) twice daily Torsemide once daily
3. Potassium-Sparing Diuretics:1. Non-aldosterone antagonists: Triamterene & Amiloride.2. Aldosterone antagonists (more potent) : Spironolactone &
Eplerenone
17
1- Thiazide Diuretics
• Indication: of choice for treating HT (it has both diuretic & direct VD effect) all are equally effective.
• Dosage: Starting dose of HCTZ (Esidrex) or chlorthalidone of 12.5 mg once daily. Maintenance dose of 25 mg once daily effectively lower BP with low
incidence of SE.
• SE: Hpokalemia , Hyponatremia , Hypomagnesemia, Hypochloremic
alkolosis Hyper uricemia , Hyper glycemia , Hyper lipidemia , Hyper sensitivity
Hypercalcemia
18
Ca++
12/11/2010
Dr. Ahmed Elberry, MD 10
2- Loop diuretics
• Indication: of choice for:
severe CKD (GFR<30 mL/min./1.73 m2) Lt ventricular dysfunction, or severe edema (because potent
diuresis is often needed in these patients).
• SE: Hpokalemia , Hyponatremia , Hypomagnesemia, Hypochloremic
alkolosis Hyper uricemia , Hyper glycemia , Hyper lipidemia , Hyper
sensitivity Hypocalcemia, Deafness, Dehydration
NB.: Loop diuretics have less effect on serum lipids & glucose19
Ca++
Hypokalemia
• Manifestation: Muscle fatigue or cramps. Serious cardiac arrhythmias may occur, esp. in patients:
receiving digitalis, with LV hypertrophy, with IHD.
• Monitoring: Serum K+ should be measured at baseline & within 4 w of
initiating therapy or after increasing diuretic doses.
• Management:1. Intermittent use of the least effective dose2. K+ rich food (bananas, potatoes, avocados)3. KCl supplement (20 – 40 mEq/day)4. Add K+ sparing diuretic
20
K+
12/11/2010
Dr. Ahmed Elberry, MD 11
3- K+-Sparing Diuretics
Indication: Patients who develop hypokalemia while on a thiazide diuretic.
SE: Hyperkalemia, especially in:
chronic kidney disease DM, concurrent treatment with an ACE.I, ARB, NSAID, or K+
supplement.
Gynecomastia with Spironolactone(in up to 10% of patients), but this effect occursrarely with eplerenone.
21
ACEIs
12/11/2010
Dr. Ahmed Elberry, MD 12
ACEIs1. S.H containing:
Captopril (capoten): [Active drug, given 2-3 timesdaily, absorption is affected by food]
2. Non-S.H containing: Active drug
Lisinopril (zestril) & Enalaprilate (given IV in emergencyhypertension)
Prodrugs Enalapril (renitec) - Perindopril - Benazepril -
Ramipril – Trandolapril - Fosinopril
24
NB.: Enalaprilate (enalaprilic acid) is the active metabolite of Enalapril ACE.I is more effective in young white patients than in black or elderly
12/11/2010
Dr. Ahmed Elberry, MD 13
ACEIsSide effects:1) Related to S.H:
1. Allergy2. Taste (Dysgeusia)3. Protinuria4. Neutropenia
2) Related to ACE1. Cough due to bradykinin2. 1st dose Hypotension (esp. in elderly & heart failure). So tart with
low dose with slow dose titration3. Hyperkalemia4. ARF esp. in bilateral renal art. stenosis
25
ACEIs
Contraindications:1. Hypotension2. Pregnancy (They are fetopathic may cause
oligohydramnios – pulmonary hypoplasia – growthretardation – fetal death)
3. Bilateral renal artery stenosis
Drug interactions:1. Na+ depleting diuretics initial Hypotension2. K+ retaining diuretics hyperkalemia3. NSAID Hypotensive Effect Through Inhibition of
Bradykinin & PGs4. Antacids absorption
26
12/11/2010
Dr. Ahmed Elberry, MD 14
AT-II Blockers (ARBs)
Candesartan - Losartan (Cozar) - Olmesartan –Valsartan – Eprosartan -Irbesartan – Telmisartan
Actions & Uses As ACEI Side effects As ACEI but with less cough
27
CCB
Classification: Dihydropyridine:
Short acting: Nifedipine (Adalat, Epilat) Long acting: Amlodipine (Norvasc) – nisoldipine – felodipine –
isradipine
Non-dihydropyridine: Verapamil (isoptin) – Diltiazem (cardizem)
Side effects:1. Bl.V.: Headache – flush – Hypotension – ankle oedema2. Heart:
Bradycardia with Diltiazem & marked with verapamil Reflex Tachycardia with nifedipine
3. G.I.T.: Constipation is marked with verapamil.
28
12/11/2010
Dr. Ahmed Elberry, MD 15
β-Blockers
Mechanism of antihypertensive effect:1. Block -1 of Heart COP.2. Block -1 of CNS Sympathetic outflow.3. Block -1 of Kidney Renin.4. Block Pre-synaptic Release of Nor-adr.5. Resetting the sensitivity of Baro-receptors.6. Prostacyclin (VD) synthesis
Classification:1. according to Selectivity2. according to Lipid solubility
29
PGs
Classification according to Selectivity
30
ISA L.A NotesA. Non- selective:
Pindolol + +Oxprenolol + +Propranolol (Inderal) No + Extensive hepatic 1st pass metabolismSotalol No NoNadolol No NoTimolol No No Eye drop in glaucoma.
B. Cardio-selective (B1)Acebutolol + +Atenolol (Tenormin) No NoBisoprolol (Concor) No NoBetaxolol No NoMetoprolol (Lopressor) No +Esmolol No No Ultrashort. I.V. Infusion.
12/11/2010
Dr. Ahmed Elberry, MD 16
NB.: Vasodilator B- Blockers:
1. 2-Partial agonist: Celiprolol: (Selective 1 Block – No ISA – No LA)
2. Nitrogenic effect ( production of NO): Nebivolol
3. 1-blocking effect: Labetalol – Bucindolol – Carvedilol (dilatrend) - Medraxalol
Classification of according to Lipidsolubility
32
Lipophilic Hydrophilic1. G.I.T. Absorption: - Well Absorbed. - Poorly absorbed.2. Passage across
B.B.B.:- Pass BBB- has CNS. effects.
- Not pass BBB- has little CNS effect
3. Metabolism: - Extensive hepatic. - Mainly Renal.4. Duration of Action: - Short (4-6 Hours) - Longer (12-24 Hs)5. Examples: - Propranolol.
- Oxprenolol.- Metoprolol.- Timolol
- Nadolol.- Atenolol.- Sotalol.- Bisoprolol
12/11/2010
Dr. Ahmed Elberry, MD 17
SE & contraindications
33
Side effects ContraindicationsI. CNS: - Sedation - depression - sleep disturbances
(only in lipophilic B.B. crossing BBB)Severe depression
(use hydrophilic B.B.)
II. CVS:1.Heart:
2.B.V.
3.B.P.
1.Heart failure - Heart block - Bradycardia ----
2.Cold extremities, Raynaud's phenomenon, numbness,tingling
3.Hypotension---------------------------------------
• H.F. - Hear block - severe bradycardia• With Verapamil: H.F. & H. Block• Variant angina .• Raynaud's phenomenon & P.V.D & alone
in pheochromocytoma• Hypotension
III. Respiration - Precipitate acute attack of B.A. in asthmatics - Bronchial asthma (use selective B1)
IV. Metabolism 1. Hypoglycemia (severe in patient receiving insulin ororal hypoglycemic [coma can occur without warning(silent death) ]
2. Hyperkalemia3. Atherosclerosis ( HDL & Triglycerides)
• Hypoglycemia in insulin or oralhypoglycemic treatment.
V. Others Sudden withdrawal withdrawal syndrome sympathetic over activity and precipitation of anginalattack even myocardial infarction
• Never stop suddenly.
α1-Receptor Blockers
Prazosin (Minipress), terazosin, and doxazosin (Cardura)
Side Effects:1. Initial Syncopal Attack (1st dose phenomenon). An αattack of
severe postural hypotension. Start by small dose while patientis recumbent (At Bed Time), then increase the dose gradually
2. Sexual dysfunction after long use in males & failure ofejaculation
3. Salt & H2O retention as it C.O. R.B.F. So, Diuretic isadded.
34
12/11/2010
Dr. Ahmed Elberry, MD 18
Central α2-Agonists Include:
Clonidine, guanabenz, guanfacine, & methyldopa
Mechanism: Selective α2 & Imidazoline I1 Agonist (15 : 1) Hypotension by:
1. Sympathetic outflow from C.N.S.2. Presynaptic Release of N.A.3. Kidney: Release of Renin
Side effects of centrally acting drugs1. Sudden Withdrawal Rebound severe hypertension
Treat by Re-using Clonidine or by -Blocker + -Blocker.2. Sedation3. Dry mouth (xerostomia) & Dry nasal mucosa
35
Moxonidine (physiotens) & Rilmenidine (Hyperium): They are selective I1 agonist used in ttt of
hypertension Less liable to cause sedation
36
12/11/2010
Dr. Ahmed Elberry, MD 19
Peripheral adrenergic neuronedepressants
Include Guanethidine Reserpine Methyldopa (act centrally also)
37
38
Guanethidine Reserpine -Methyldopa*Kinetic *Kinetic: *Kinetic- Incompletely absorbed- Not pass B.B.B- Slowly excreted in urine
- Well absorbed- Passes B.B.B- Slowly excreted in urine
- Well absorbed- Passes B.B.B- Transformed to -methyl
NAMechanism (Release) Mechanism: (Depletion) Mechanism ( synthesis &
Central)* Side effects: * Side effects: * Side effects:1) Parasymp. Predominance:
1. Nasal congestion2. Bradycardia3. Postural hypotension4. Diarrhea
2) Others:1. Parotid pain
2. Failure of ejaculation
1) Parasymp. Predominance:1.Nasal congestion{Stuffiness}
2.Bradycardia3.Hypotension4.Diarrhea
2) Others:1. Na & H2O retention2.Weight gain3.Peptic ulcer4.Endocrinal disturbance5.Breast cancer.6.Impotence
3) C.N.S:1. Psychic depression2. Nightmares3. Parkinsonism
1) Parasymp. Predominance:1.Nasal congestion2.Bradycardia3.Hypotension4.Diarrhea
2) Other:1.Na & H20 retention weight
gain2.Liver toxicity3.Bone marrow
Depression3) C.N.S:
1. Psychic depression2. Night mares3. Parkinsonism4. Sedation
12/11/2010
Dr. Ahmed Elberry, MD 20
Direct renin inhibitors(Aliskirin (Tecturna®))
Inhibit directly the renin Similar to ACEIs & ARBs & contraindicated in
pregnancy Used once orally as an alternative antihypertensive
agent
Direct Arterial Vasodilators Include:
Hydralazine - Minoxidil - Diazoxide
Actions & effects :1. Direct Arterio-dilator Bl.Pr useful in Hypertension2. Bl.Pr symp & after load Co useful in H.F
Disadvantages & general SE:1. Bl.Pr sympathetic leading to: Tachycardia & Angina [Add - blockers] Rennin edema [Add diuretic](So, they are not used alone, but used in combinationwith - blockers & diuretics)
2. V.D Headache – congestion – flush
40
12/11/2010
Dr. Ahmed Elberry, MD 21
41
(1)Hydralazine (2) Minoxidil (3) Diazoxide
Side effects1. Hypersensitivity in the form of:- Rash- Rheumatoid arthritis- Systemic lupus
erythematosus likesyndrome
2. GIT upset3. Peripheral neuritis
. Hypertrichosis 1. Hyperglycemia2. Hyperuricemia(as it is related to Thiazide
diuretic)
UsesOrally& I.V1. Hypertension & emergency2. H.F
Orally1. Hypertension2. H.F3. Locally in alopecia
I.VEmergency Hypertension
SPECIAL POPULATIONS
• Pregnancy: Methyldopa is the drug of choice Alternatives: ΒB & CCBs. ACEI & ARBs are contraindicated (teratogens).
• African Americans: Thiazides & CCBs are particularly effective. Response is significantly when either class is
combined with a BB, ACEI, or ARB.
• Older People: Diuretics & ACEI can be used safely, but in smaller-
than-usual initial doses, and titrations should occurover a longer period to minimize the risk ofhypotension.
Centrally acting agents & BB should be avoided orused with caution because they are associated withdizziness & postural hypotension.
12/11/2010
Dr. Ahmed Elberry, MD 22
HYPERTENSIVE CRISIS
˃ 180/110 & may be classified into:
Hypertensive urgency: without target organ damage (TOD) (eg. Encephalopathy,
unstable angina, renal failure & papilledema) ttt: adjusting maintenance therapy by adding a new
antihypertensive and/or increasing the dose of a present drug.
Hypertensive emergency: with TOD ttt: require immediate BP reduction to limit new or progressing
target-organ damage.
43
This image cannot currently be displayed.
Goal in treatment of hypertensivecrisis
The goal: not to lower BP to normal; as rapid drops in BP may cause end-
organ ischemia or infarction.
The initial target is MAP 25% within minutes to hours. If BP is then stable, it can be reduced to 160/100 -110 mm Hg
within the next 2-6 hours. Additional gradual decrease toward the goal BP after 24 -48
hours.
44
12/11/2010
Dr. Ahmed Elberry, MD 23
Treatment of hypertensive crises
Hypertensive urgency: Hypertensive emergency:Acute administration of short-actingoral drugs (captopril or labetalol)followed by careful observation forseveral hours to ensure gradual BPreduction.
• Captopril 25-50 mg may be givenat 1- to 2-hour intervals. The onsetof action is 15- 30 min.
• Labetalol 200-400 mg, followed byadditional doses every 2- 3 h.
Nitroprusside is the drug of choice inmost cases.
• Given as a IV infusion (0.25 to 10mcg/kg/min.)
• Onset of action is immediate &disappears within 1-2 min ofdiscontinuation.
• When infusion is continued ˃72 h.,serum thiocyanate levels should bemeasured, & infusion should bestopped if the level ˃12 mg/dL.
Other Parentral drugs used inemergency HT
Nitroprusside Nitroglycerin Nicardipine
Diazoxide Esmolol Enalaprilate Fenoldopam
Hydralazine Labetalol
46
12/11/2010
Dr. Ahmed Elberry, MD 24
Causes of Resistant HT
1. Improper BP measurement2. Identifiable causes of HTN
3. Excess sodium intake4. Excess alcohol intake
5. Inadequate diuretic or medication therapy6. Drug actions and interactions:
• NSAIDs, sympathomimetics, oral contraceptives,OTC drugs & herbal supplements